INSP Inspire Medical Systems Inc

$86.35

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Inspire Medical Systems is poised to capture investor attention as it approaches its upcoming earnings release, with a market cap of approximately $2.39 billion underscoring its significant presence in the medical device sector. Despite the EPS estimate and whisper number both standing at $0.00, indicating a neutral earnings expectation, the focus will likely shift to the company's revenue performance, projected at $220.40 million. This revenue estimate will be a critical indicator of Inspire's ability to maintain its growth trajectory, especially in the absence of recent news or strategic developments. Investors will be keen to see if the company can meet or exceed this revenue target, as it would signal continued demand for its innovative sleep apnea solutions. As the earnings date approaches, market sentiment will likely hinge on Inspire's capacity to leverage its market position and deliver on revenue expectations, providing a clearer picture of its financial health and future prospects.

Updated On 11/16/2025

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.

Website: https://www.inspiresleep.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1609550
Address
5500 WAYZATA BLVD, SUITE 1600, GOLDEN VALLEY, MN, US
Valuation
Market Cap
$4.47B
P/E Ratio
85.35
PEG Ratio
nan
Price to Book
6.48
Performance
EPS
$1.76
Dividend Yield
Profit Margin
6.67%
ROE
8.48%
Technicals
50D MA
$168.18
200D MA
$180.98
52W High
$257.40
52W Low
$123.00
Fundamentals
Shares Outstanding
30M
Target Price
$226.07
Beta
1.39

INSP EPS Estimates vs Actual

Estimated
Actual

INSP News & Sentiment

Nov 16, 2025 • Business Insider SOMEWHAT-BULLISH
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
Nov 15, 2025 • Business Insider SOMEWHAT-BULLISH
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
Nov 15, 2025 • Benzinga SOMEWHAT-BULLISH
STOCK ALERT: Inspire Medical Systems, Inc. ( INSP ) Investors may be Eligible for Compensation in Securities Class Action - Contact BFA Law by January 5 Deadline - Inspire Medical Systems ( NYSE:INSP )
NEW YORK, Nov. 15, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ( NYSE:INSP ) and certain of the Company's senior executives for securities fraud after a significant ...
Nov 14, 2025 • Benzinga NEUTRAL
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inspire Medical Systems, Inc. ( INSP ) Shareholders - Inspire Medical Systems ( NYSE:INSP )
NEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ( "Inspire Medical Systems, Inc." or the "Company" ) ( NYSE:INSP ) of a class action securities lawsuit.
Nov 14, 2025 • Benzinga SOMEWHAT-BULLISH
Inspire Medical Systems, Inc. ( INSP ) Faces Investor Suit Over Disastrous Inspire V Launch - Hagens Berman - Inspire Medical Systems ( NYSE:INSP )
SAN FRANCISCO, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. ( NYSE:INSP ) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical "next generation" sleep apnea device, the Inspire ...
Nov 13, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for INSP, TLX, and LRN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Inspire Medical Systems ( NYSE:INSP ) , Stride ( NYSE:LRN )
LOS ANGELES, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Sentiment Snapshot

Average Sentiment Score:

0.201
50 articles with scored sentiment

Overall Sentiment:

Bullish

INSP Reported Earnings

Aug 04, 2025
Jun 30, 2025 (Post market)
0.25 Surprise
  • Reported EPS: $0.45
  • Estimate: $0.20
  • Whisper:
  • Surprise %: 125.0%
May 05, 2025
Mar 31, 2025 (Post market)
0.33 Surprise
  • Reported EPS: $0.10
  • Estimate: $-0.23
  • Whisper:
  • Surprise %: 143.5%
Feb 10, 2025
Dec 31, 2024 (Post market)
0.43 Surprise
  • Reported EPS: $1.15
  • Estimate: $0.72
  • Whisper:
  • Surprise %: 59.7%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.54 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.06
  • Whisper:
  • Surprise %: 900.0%
Aug 06, 2024
Jun 30, 2024 (Post market)
0.46 Surprise
  • Reported EPS: $0.32
  • Estimate: $-0.14
  • Whisper:
  • Surprise %: 328.6%
May 07, 2024
Mar 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.65
  • Whisper:
  • Surprise %: 47.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.58 Surprise
  • Reported EPS: $0.49
  • Estimate: $-0.09
  • Whisper:
  • Surprise %: 644.4%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.29 Surprise
  • Reported EPS: $-0.29
  • Estimate: $-0.58
  • Whisper:
  • Surprise %: 50.0%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.16 Surprise
  • Reported EPS: $-0.41
  • Estimate: $-0.57
  • Whisper:
  • Surprise %: 28.1%

Financials